Back to search

Article

CRISPR-SID: identifying EZH2 as a druggable target for desmoid tumors via <i>in vivo</i> dependency mapping

2019-04-01

Abstract excerpt

Cancer precision medicine implies identification of tumor-specific vulnerabilities associated with defined oncogenic pathways. Desmoid tumors are soft-tissue neoplasms strictly driven by Wnt signaling network hyperactivation. Despite this clearly defined genetic etiology and the strict and unique implication of the Wnt/β-catenin pathway, no specific molecular targets for these tumors have been identified. To addre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2415c980-060f-5d3a-912b-487f5bddb181
DOI
10.1101/595769
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-SID: identifying EZH2 as a druggable target for desmoid tumors via <i>in vivo</i> dependency mappingDOI 10.1101/595769
Select a neighboring publication to make it the new centre.